Xilio Therapeutics, Inc.XLONASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank33
3Y CAGR-24.1%
5Y CAGR+22.6%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-24.1%/yr
Annual compound
5Y CAGR
+22.6%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20252.58+16.6%
20242.21-26.7%
20233.02-48.8%
20225.89-62.8%
202115.85+1605.4%
20200.93-90.5%
20199.81-